Emerald Bioscience Provides Update on Recent Progress and Expected 2020 Milestones
13. Januar 2020 08:30 ET
|
Emerald Bioscience, Inc.
Company prepares to enter the clinic in 2020 to test NB1111 (THCVHS) in glaucoma Preclinical formulation testing proprietary analog of CBD examining the utility of CBDVHS in the eye, brain, and...